Innovation1 Biotech Inc.
IVBT · OTC
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $105 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $52 | -$0 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $0 | $0 | $15 | $0 |
| G&A Expenses | $150 | $115 | $9 | $201 |
| SG&A Expenses | $150 | $156 | $178 | $203 |
| Sales & Mktg Exp. | $0 | $41 | $170 | $2 |
| Other Operating Expenses | $0 | $0 | -$380 | $0 |
| Operating Expenses | $150 | $156 | -$201 | $204 |
| Operating Income | -$150 | -$156 | $201 | -$204 |
| % Margin | – | – | 192% | – |
| Other Income/Exp. Net | -$139 | -$99 | -$4,656 | -$95 |
| Pre-Tax Income | -$290 | -$255 | -$4,454 | -$299 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$290 | -$255 | -$4,454 | -$299 |
| % Margin | – | – | -4,247.1% | – |
| EPS | -0.023 | -0.023 | -0.23 | -0.03 |
| % Growth | -1.3% | 90% | -666.7% | – |
| EPS Diluted | -0.023 | -0.023 | -0.23 | -0.03 |
| Weighted Avg Shares Out | 22,470 | 21,122 | 20,470 | 20,323 |
| Weighted Avg Shares Out Dil | 22,470 | 21,122 | 20,473 | 20,323 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $139 | $104 | $116 | $95 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$150 | -$151 | -$4,338 | -$203 |
| % Margin | – | – | -4,136.5% | – |